Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Cited by (1,003)

Items 501–600 of 1,003

1. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFκB activation in epithelial derived cell lines
   Shashirekha Shetty, J. Brown Gladden, Elizabeth S. Henson, Xiaojie Hu, Jacylyn Villanueva, Neil Haney, Spencer Bruce Gibson · 2002 · APOPTOSIS
2. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
   Shi‐Yong Sun, Ping Yue, Waun Ki Hong, Reuben Lotan · 2000 · PubMed
3. Tumor Associated Macrophages Protect Colon Cancer Cells from TRAIL-Induced Apoptosis through IL-1β- Dependent Stabilization of Snail in Tumor Cells
   Pawan Kaler, Vincent P. Galea, Leonard H. Augenlicht, Lidija Klampfer · 2010 · PLoS ONE
4. Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Induces Death Receptor 5 Networks That Are Highly Organized
   Christopher C. Valley, Andrew K. Lewis, Deepti J. Mudaliar, Jason D. Perlmutter, Anthony R. Braun, Christine B. Karim, David Dale Thomas, Jonathan Robert Brody, Jonathan N. Sachs · 2012 · Journal of Biological Chemistry
5. Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer
   Fumiaki Ozawa, Helmut Friess, Jorg H. Kleeff, Zhongwei Xu, A. Zimmermann, M. Saeed Sheikh, Markus Wolfgang Büchler · 2001 · Cancer Letters
6. Cholestasis Increases Tumor Necrosis Factor-Related Apoptotis-Inducing Ligand (TRAIL)-R2/DR5 Expression and Sensitizes the Liver to TRAIL-Mediated Cytotoxicity
   Hajime Higuchi, Steven F. Bronk, Makiko Taniai, Ali E. Canbay, Gregory James Gores · 2002 · Journal of Pharmacology and Experimental Therapeutics
7. Evidence for a Role of TNF-Related Apoptosis-Inducing Ligand (TRAIL) in the Anemia of Myelodysplastic Syndromes
   Diana Campioni, Paola Secchiero, Federica Corallini, Elisabetta Melloni, Silvano Capitani, Francesco Lanza, Giorgio Zauli · 2005 · American Journal Of Pathology
8. Cell death in drug-induced liver injury
   Andrea Iorga, Lily Dara · 2019 · Advances in pharmacology
9. Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
   Tuong Nguyen, Xu Dong Zhang, Peter Hersey · 2001 · PubMed
10. Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis
    Patrizia Marini, A. Schmid, Verena Jendrossek, Heidrun Faltin, Peter T. Daniel, Wilfried Budach, Claus Belka · 2005 · BMC Cancer
11. TRAIL Gene Therapy: From Preclinical Development to Clinical Application
    Thomas S. Griffith, Brittany Stokes, Tamara A. Kucaba, James K. Earel, Rebecca L. VanOosten, Erik L. Brincks, Lyse A. Norian · 2009 · Current Gene Therapy
12. Apoptosis and the response to anticancer therapy
    Benjamin M. F. Mow, April L. Blajeski, Joya Chandra, Scott H. Kaufmann · 2001 · Current Opinion in Oncology
13. Mesenchymal Stem Cells as a Novel Carrier for Targeted Delivery of Gene in Cancer Therapy Based on Nonviral Transfection
    Yulan Hu, Bin Huang, Tianyuan Zhang, Pei‐Hong Miao, Guping Tang, Yasuhiko Tabata, Jianqing Gao · 2012 · Molecular Pharmaceutics
14. Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
    Haipeng Liu, Danmei Su, Jinlong Zhang, Shuai‐Shuai Ge, Youwei Li, Fei Wang, Michel Gravel, Anne Roulston, Song Qin, Wei Min Xu et al. · 2017 · Scientific Reports
15. Target Cell–Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7
    Edwin Bremer, Douwe Freerk Samplonius, Matthias Peipp, Linda van Genne, Bart‐Jan Kroesen, Georg H. Fey, Martin Gramatzki, Lou F. M. H. de Leij, Wijnand Helfrich · 2005 · Cancer Research
16. Nanoparticle‐Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma
    Kui Wang, Forrest M. Kievit, Mike Jeon, John R. Silber, Richard G. Ellenbogen, Miqin Zhang · 2015 · Advanced Healthcare Materials
17. TNF Superfamily: A Growing Saga of Kidney Injury Modulators
    María Dolores Sánchez-Niño, Alberto Benito‐Martín, Sara Gonçalves, Ana Belen Sanz, Alvaro Conrado Ucero, María Concepción Izquierdo, Adrian Mario Ramos, Sergio Berzal, Rafael Selgas, Marta Ruiz‐Ortega et al. · 2010 · Mediators of Inflammation
18. Cyclooxygenase-2 Inhibition Sensitizes Human Colon Carcinoma Cells to TRAIL-Induced Apoptosis through Clustering of DR5 and Concentrating Death-Inducing Signaling Complex Components into Ceramide-Enriched Caveolae
    Sophie Martin, Darren C. Phillips, Kinga Székely Szücs, Lynda Elghazi, Fabienne Desmots, Janet A. Houghton · 2005 · Cancer Research
19. Inducible Release of TRAIL Fusion Proteins from a Proapoptotic Form for Tumor Therapy
    Khalid Shah, Ching‐Hsuan Tung, Katherine S. Yang, Ralph Weissleder, Xandra O. Breakefield · 2004 · Cancer Research
20. Type I and type II reactions in TRAIL-induced apoptosis – results from dose–response studies
    Justine Rudner, Verena Jendrossek, Kirsten Lauber, Peter T. Daniel, Sebastian Wesselborg, Claus Belka · 2004 · Oncogene
21. Wogonin and Related Natural Flavones Overcome Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Protein Resistance of Tumors by Down-regulation of c-FLIP Protein and Up-regulation of TRAIL Receptor 2 Expression
    Jie Ding, Gernot Polier, Rebecca Köhler, Marco Giaisi, Peter H. Krammer, Min Li‐Weber · 2011 · Journal of Biological Chemistry
22. The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells
    Mano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Miki Wakada, Ryoko Nakanishi, Hoyoku Nishino, Toshiyuki Sakai · 2005 · Biochemical and Biophysical Research Communications
23. Target cell‐restricted and ‐enhanced apoptosis induction by a scFv:sTRAIL fusion protein with specificity for the pancarcinoma‐associated antigen EGP2
    Edwin Bremer, Jos M. A. Kuijlen, Douwe Freerk Samplonius, Henning Walczak, Lou de Leij, Wijnand Helfrich · 2003 · International Journal of Cancer
24. Atypical Teratoid/Rhabdoid Tumors of the Central Nervous System
    Alyssa Terry Reddy · 2005 · Journal of Neuro-Oncology
25. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression
    Juan Du, Xiaohong Liang, Yugang Liu, Z Qu, Lifen Gao, Lihui Han, S Liu, M Cui, Yongyu Shi, Zhenyu Zhang et al. · 2008 · Cell Death and Differentiation
26. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1
    Sara Huerta‐Yépez, Mario I. Vega, Saul E. Escoto-Chavez, Benjamin J. Murdock, Toshiyuki Sakai, Stavroula Baritaki, Benjamin Bonavida · 2008 · Nitric Oxide
27. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27Kip1 and control of cyclin D1 expression
    Alessandra Cappellini, Giovanna Tabellini, Marina Zweyer, Roberta Bortul, Pier Luigi Tazzari, A.M. Billi, Federica Falà, Lucio Cocco, A M Martelli · 2003 · Leukemia
28. ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis
    Jin Hyang Song, Karthikeyan Kandasamy, Andrew S. Kraft · 2008 · Journal of Biological Chemistry
29. Surface-Enhanced Raman Scattering-Based Sensing In Vitro: Facile and Label-Free Detection of Apoptotic Cells at the Single-Cell Level
    Xiangxu Jiang, Ziyun Jiang, Tingting Xu, Shao Su, Yiling Zhong, Fei Peng, Yuanyuan Su, Yao He · 2013 · Analytical Chemistry
30. Is TRAIL hepatotoxic?
    Gregory Gores, Scott H. Kaufmann · 2001 · Hepatology
31. Genetic Modification of T Lymphocytes for Adoptive Immunotherapy
    Claudia Rössig, Malcolm K. Brenner · 2004 · Molecular Therapy
32. HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP)
    Andreas Krueger, Stefanie C. Fas, Marco Giaisi, Marc Bleumink, Anette Merling, Christine Stumpf, Sven Baumann, Denise Holtkotte, Valerie Bosch, Peter H. Krammer et al. · 2006 · Blood
33. Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox
    Bora Lim, Yoshimi Endo Greer, Stanley Lipkowitz, Naoko Takebe · 2019 · Cancers
34. ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis
    S-A Quast, Anja Berger, Jürgen Eberle · 2013 · Cell Death and Disease
35. Targeting cyclooxygenase‐2 for prevention and therapy of colorectal cancer
    Frank A. Sinicrope · 2006 · Molecular Carcinogenesis
36. Role of Cell-Death Ligand-Receptor System of Granulosa Cells in Selective Follicular Atresia in Porcine Ovary
    Naoko Inoue, Fuko Matsuda, Yasufumi Goto, Noboru MANABE · 2011 · Journal of Reproduction and Development
37. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome–positive leukemia cells
    Kanako Uno, Takeshi Inukai, Nobuhiko Kayagaki, Kumiko Goi, Hiroki Sato, Atsushi Nemoto, Kazuya Takahashi, Keiko Kagami, Noriko Yamaguchi, Hideo Yagita∥ et al. · 2003 · Blood
38. Death Induction by Recombinant Native TRAIL and Its Prevention by a Caspase 9 Inhibitor in Primary Human Esophageal Epithelial Cells
    Seok‐Hyun Kim, Kunhong Kim, Jae Kwagh, David T. Dicker, Meenhard Herlyn, Anil K. Rustgi, Youhai Chen, Wafik S. El‐Deiry · 2004 · Journal of Biological Chemistry
39. Suppression of Tumor Growth Following Intralesional Therapy with TRAIL Recombinant Adenovirus
    Thomas S. Griffith, Elizabeth L. Broghammer · 2001 · Molecular Therapy
40. Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors
    Bryant G. Darnay, Bharat B Aggarwal · 1999 · Annals of the Rheumatic Diseases
41. Molecular architecture of the DED chains at the DISC: regulation of procaspase-8 activation by short DED proteins c-FLIP and procaspase-8 prodomain
    Schleich, K, Buchbinder, J H, Pietkiewicz, S, Kähne, T, Warnken, U, Öztürk, S, Schnölzer, M, Naumann, M, Krammer, P H, Lavrik, I N · 2016 · Cell Death & Differentiation
42. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-κB but is related to downregulation of initiator caspases and DR4
    Bahtier M. Kurbanov, Lothar F. Fecker, Christoph C. Geilen, Wolfram Sterry, Jürgen Eberle · 2006 · Oncogene
43. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes
    Liangran Guo, Li Fan, Zhiqing Pang, Jinfen Ren, Yulong Ren, Jingwei Li, Jie Chen, Ziyi Wen, Xinguo Jiang · 2011 · Journal of Controlled Release
44. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation
    Y-C Kang, K-M Kim, KS Lee, Seung Namkoong, SJ Lee, J-A Han, D Jeoung, Kwon‐Soo Ha, Y-G Kwon, Y-M Kim · 2004 · Cell Death and Differentiation
45. Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Agonist Antibody
    Anil Shanker, Ari D. Brooks, Carlos A. Tristan, John W. Wine, Peter J. Elliott, Hideo Yagita∥, Kazuyoshi Takeda, Mark John Smyth, William J. Murphy, Thomas Joseph Sayers · 2008 · JNCI Journal of the National Cancer Institute
46. Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Mediated Destruction
    Adriana Eramo, Roberto Pallini M. D, Fiorenza Lotti, Giovanni Sette, Mariella Patti, Monica Bartucci, Lucia Ricci‐Vitiani, Michele Signore, Giorgio Stassi, Luigi Maria Larocca et al. · 2005 · Cancer Research
47. Nitric oxide-induced apoptosis in tumor cells
    Victor Umansky, Volker Schirrmacher · 2001 · Advances in cancer research
48. Tumor necrosis factor–related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway
    Paola Secchiero, Arianna Gonelli, Prisco Mirandola, Elisabetta Melloni, Loris Zamai, Claudio Celeghini, Daniela Milani, Giorgio Zauli · 2002 · Blood
49. Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2
    Eiji Mori, M Thomas, Kazuhiro Motoki, K Nakazawa, T. Tahara, Kazuma Tomizuka, I. Ishida, Shun Kataoka · 2003 · Cell Death and Differentiation
50. Selective Inhibition of IκB Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing Cellular FLIP Level
    Gaël Roué, Patricia Pérez‐Galán, Mònica López‐Guerra, Neus Villamor, Elı́as Campo, Dolors Colomer · 2007 · The Journal of Immunology
51. Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer
    Sven Baumann, Anja Dostert, Natalia Novac, Anton Bauer, Wolfgang Schmid, Stefanie C. Fas, Andreas Krueger, Thorsten Heinzel, Sabine Kirchhoff, Günther Schütz et al. · 2005 · Blood
52. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes.
    Sorin Armeanu, Ulrich M. Lauer, Irina Smirnow, Martin Schenk, Thomas S. Weiß, Michael Gregor, Michael Bitzer · 2003 · PubMed
53. Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway
    Clarissa von Haefen, Bernhard F. Gillissen, Philipp Hemmati, Jana Wendt, Dilek Güner, Alicja Mrozek, Claus Belka, Bernd Dörken, Peter T. Daniel · 2004 · Oncogene
54. IFN-?induces cell death in human hepatoma cells through a trail/death receptor-mediated apoptotic pathway
    Eui‐Cheol Shin, Ju Mi Ahn, Chul Hoon Kim, Youjeong Choi, Young Soo Ahn, Hoguen Kim, Se‐Jong Kim, Jeon Han Park · 2001 · International Journal of Cancer
55. Akkermansia muciniphila Aspartic Protease Amuc_1434* Inhibits Human Colorectal Cancer LS174T Cell Viability via TRAIL-Mediated Apoptosis Pathway
    Xin Meng, Jinrui Zhang, Hao Wu, Dahai Yu, Xuexun Fang · 2020 · International Journal of Molecular Sciences
56. Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy
    Liangdi Jiang, Yongwei Gu, Yue Du, Xiaomeng Tang, Xin Wu, Jiyong Liu · 2021 · ACS Applied Materials & Interfaces
57. Recent Advances in CAR-Based Solid Tumor Immunotherapy
    Min Hwa Shin, Eunha Oh, Yun Jeong Kim, Dae-Hwan Nam, Soyoung Jeon, Jin Hyuk Yu, Dohsik Minn · 2023 · Cells
58. Enhancing the antitumor efficacy of a cell-surface death ligand by covalent membrane display
    Pradeep M. Nair, Heather Flores, Alvin Gogineni, Scot A. Marsters, David A. Lawrence, Robert F. Kelley, Hai Ngu, Meredith S. Sagolla, László G. Kömüves, Richard Bourgon et al. · 2015 · Proceedings of the National Academy of Sciences
59. Direct Binding of Fas-associated Death Domain (FADD) to the Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor DR5 Is Regulated by the Death Effector Domain of FADD
    Lance R. Thomas, Adrianna L. Henson, John C. Reed, Freddie R. Salsbury, Andrew M. Thorburn · 2004 · Journal of Biological Chemistry
60. Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: Involvement of ROS-dependent ER-stress
    Dong‐Oh Moon, Sung Yong Park, Yung Hyun Choi, Jong Seog Ahn, Gi‐Young Kim · 2011 · Biochemical Pharmacology
61. HIV Type 1-Infected Dendritic Cells Induce Apoptotic Death in Infected and Uninfected Primary CD4 T Lymphocytes
    Miriam Lichtner, Concepción Marañón, Olga Azocar, Daniel Hanau, Pierre Lebon, Marianne Burgard, Christine Rouzioux, Vincenzo Vullo, Hideo Yagita∥, Chantal Rabourdin‐Combe et al. · 2004 · AIDS Research and Human Retroviruses
62. Therapeutic applications of TRAIL receptor agonists in cancer and beyond
    Gustavo Pessini Amarante-Mendes, Thomas S. Griffith · 2015 · Pharmacology & Therapeutics
63. TNF superfamily control of tissue remodeling and fibrosis
    Hope Steele, Jason H. Cheng, Ashley Willicut, Garrison Dell, Joey Emery Breckenridge, Erica Culberson, Andrew Ghastine, Virginie Tardif, Rana Herro · 2023 · Frontiers in Immunology
64. Resistance of Short Term Activated T Cells to CD95-Mediated Apoptosis Correlates with De Novo Protein Synthesis of c-FLIPshort
    Ingo Schmitz, Heiko Weyd, Andreas Krueger, Sven Baumann, Stefanie C. Fas, Peter H. Krammer, Sabine Kirchhoff · 2004 · The Journal of Immunology
65. Leukocytes as carriers for targeted cancer drug delivery
    Michael J. Mitchell, Michael R. King · 2014 · Expert Opinion on Drug Delivery
66. TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5
    Johannes Lemke, Andreas Noack, Dieter Adam, Vladimir Tchikov, Uwe Bertsch, Christian Röder, Stefan Schütze, Harald Wajant, Holger Kalthoff, Anna Trauzold · 2010 · Journal of Molecular Medicine
67. Applications of neural and mesenchymal stem cells in the treatment of gliomas
    Thomas A. Kosztowski, Hasan A. Zaidi, Alfredo Quiñones‐Hinojosa · 2009 · Expert Review of Anticancer Therapy
68. Pancreatic Adenocarcinoma Cell Lines Show Variable Susceptibility to TRAIL-Mediated Cell Death
    Saleh Mohamed Ibrahim, Jörg Ringel, Christian Schmidt, Bruno Ringel, Petra Müller, Dirk Koczan, Hans‐Jürgen Thiesen, Matthias J. Löhr · 2001 · Pancreas
69. The Complexity of TNF‐Related Apoptosis‐Inducing Ligand
    Karon Abe, Alexei V. Kurakin, MEHRDAD MOHSENI‐MAYBODI, Brian K. Kay, Roya Khosravi‐Far · 2000 · Annals of the New York Academy of Sciences
70. Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis
    Kenya Yamaguchi, Robert G. Uzzo, Julia S. Pimkina, Peter B. Makhov, Konstantin V. Golovine, Paul L. Crispen, Vladimir M. Kolenko · 2005 · Oncogene
71. Treatment of Experimental Glioma by Administration of Adenoviral Vectors Expressing Fas Ligand
    Benjamin B. Ambar, Karl Frei, Ursula Malipiero, Adrián E. Morelli, Maria Graciela Castro, Pedro Ricardo Lowenstein, Adriano Fontana · 1999 · Human Gene Therapy
72. TRAIL receptor targeting therapies for non-small cell lung cancer: Current status and perspectives
    Janet H. Stegehuis, Leonie H.A.M. de Wilt, Elisabeth G.E. de Vries, Harry J.M. Groen, Steven de Jong, Frank A.E. Kruyt · 2009 · Drug Resistance Updates
73. Transformation by Oncogenic RAS Sensitizes Human Colon Cells to TRAIL-induced Apoptosis by Up-regulating Death Receptor 4 and Death Receptor 5 through a MEK-dependent Pathway
    Konstantinos G. Drosopoulos, Michael L. Roberts, Lukáš C̆ermák, Takehiko Sasazuki, Senji Shirasawa, Ladislav Anděra, Alexander Pintzas · 2005 · Journal of Biological Chemistry
74. Expression, regulation and function of trail in atherosclerosis
    Mary Meltem Kavurma, Martin R. Bennett · 2007 · Biochemical Pharmacology
75. Histone Deacetylase Inhibitors Modulate the Sensitivity of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Resistant Bladder Tumor Cells
    James K. Earel, Rebecca L. VanOosten, Thomas S. Griffith · 2006 · Cancer Research
76. Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3.
    Touraj Abdollahi, Noreen M. Robertson, Abbas Abdollahi, Gerald Litwack · 2003 · PubMed
77. Targeted Inhibition of ULK1 Promotes Apoptosis and Suppresses Tumor Growth and Metastasis in Neuroblastoma
    Christopher M. Dower, Neema Bhat, Melat T. Gebru, Longgui Chen, Carson A. Wills, Barbara A. Miller, Hong‐Gang Wang · 2018 · Molecular Cancer Therapeutics
78. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
    Thomas S. Griffith, Jonathan Fialkov, David L Scott, Takeo Azuhata, Richard Dafydd Williams, Nathan R. Wall, Dario C. Altieri, Anthony David Sandler · 2002 · PubMed
79. Expression ofTRAILand Its Receptors in Human Brain Tumors
    Frank Stephan, Uta Köhler, Gabriele Schackert, Hans K. Schackert · 1999 · Biochemical and Biophysical Research Communications
80. CD95L/FasL and TRAIL in Tumour Surveillance and Cancer Therapy
    Harald Wajant · 2006 · Cancer treatment and research
81. Tumor-derived Mutations in the TRAIL Receptor DR5 Inhibit TRAIL Signaling through the DR4 Receptor by Competing for Ligand Binding
    Lianghua Bin, Jacqueline Thorburn, Lance R. Thomas, Peter E. Clark, Robin C. Humphreys, Andrew M. Thorburn · 2007 · Journal of Biological Chemistry
82. IFN-α–Induced Apoptosis in Hepatocellular Carcinoma Involves Promyelocytic Leukemia Protein and TRAIL Independently of p53
    Kerstin Herzer, Thomas G. Hofmann, Andreas Teufel, Christoph C. Schimanski, Markus Hermann Moehler, Stephan Kanzler, Henning Schulze‐Bergkamen, Peter R. Galle · 2009 · Cancer Research
83. Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
    Agathe Dubuisson, Olivier Micheau · 2017 · Antibodies
84. TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy
    Lisa F. Lincz, T-X Yeh, Andrew G Spencer · 2001 · Leukemia
85. The Role of Caspase-2 in Regulating Cell Fate
    Vasanthy Vigneswara, Zubair Ahmed · 2020 · Cells
86. Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis
    Manuela Hornle, Nathalie Peters, B Thayaparasingham, Hanna Vörsmann, Hamid Kashkar, Dagmar Kulms · 2010 · Oncogene
87. Lysosomes and endoplasmic reticulum: Targets for improved, selective anticancer therapy
    Stig T. Linder, Mohamed Monai Shoshan · 2005 · Drug Resistance Updates
88. Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles
    Sung Mook Lim, Tae Hyung Kim, Hai Hua Jiang, Chan Woong Park, Seulki Lee, Xiaoyuan Shawn Chen, Kang Choon Lee · 2011 · Biomaterials
89. Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells
    H. Hasegawa · 2005 · Blood
90. Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel.
    Junichi Asakuma, Makoto Sumitomo, Takako Asano, Tomohiko Asano, Masamichi Hayakawa · 2003 · PubMed
91. A Novel Anti-human DR5 Monoclonal Antibody with Tumoricidal Activity Induces Caspase-dependent and Caspase-independent Cell Death
    Yabin Guo, Caifeng Chen, Yong Zheng, Jinchun Zhang, Xiaohui Tao, Shilian Liu, Dexian Zheng, Yanxin Liu · 2005 · Journal of Biological Chemistry
92. Predicting human safety: screening and computational approaches
    Dale E Johnson, Grushenka H.I. Wolfgang · 2000 · Drug Discovery Today
93. Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor–related apoptosis-inducing ligand
    Liqing Zhuang, C. Soon Lee, Richard A. Scolyer, Stanley W. McCarthy, Xu Dong Zhang, John F. Thompson, Gavin Robert Screaton, Peter Hersey · 2006 · Human Pathology
94. Genomic Organization and Transcriptional Regulation of Human Apo2/TRAIL Gene
    Bendi Gong, Alexandru Almasan · 2000 · Biochemical and Biophysical Research Communications
95. Complete Regression of Metastatic Renal Cell Carcinoma by Multiple Injections of Engineered Mesenchymal Stem Cells Expressing Dodecameric TRAIL and HSV-TK
    Sae Won Kim, Su Jin Kim, Sang Hoon Park, Hyun Gul Yang, Moon Cheol Kang, Young Woo Choi, Seong Muk Kim, Sin‐Soo Jeun, Young Chul Sung · 2012 · Clinical Cancer Research
96. TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress
    Florent Dufour, Thibault Rattier, Andrei Alexandru Constantinescu, Luciana Zischler, Aymeric Morlé, Hazem Ben Mabrouk, Étienne Humblin, Guillaume Jacquemin, Éva Szegezdi, Fabien Delacôte et al. · 2016 · Oncotarget
97. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy
    Shiyang Shen, Meng Liu, Teng Li, Shiqi Lin, Ran Mo · 2017 · Biomaterials Science
98. Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib
    Daniele Lecis, Carmelo Drago, Leonardo Manzoni, Pierfausto Seneci, Carlo Scolastico, Eloise Mastrangelo, Martino Bolognesi, Andrea Anichini, Hamid Kashkar, Henning Walczak et al. · 2010 · British Journal of Cancer
99. Suppression of NF-κB Survival Signaling by Nitrosylcobalamin Sensitizes Neoplasms to the Anti-tumor Effects of Apo2L/TRAIL
    Mamta Chawla‐Sarkar, Joseph Alan Bauer, Joseph A. Lupica, Bei Morrison, Zhuo Tang, Rhonda K. Oates, Alexandru Almasan, Joseph A. DiDonato, Ernest C. Borden, Daniel J. Lindner · 2003 · Journal of Biological Chemistry · Retracted
100. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP
     Eun Hee Kim, Hee Sue Kim, Seung Up Kim, Eun Joo Noh, Jong‐Soo Lee, Kyeong Sook Choi · 2005 · Oncogene